Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update
07. Mai 2024 04:09 ET
|
AKAMPION
Geneva (Switzerland), May 7, 2024 – Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, today announced the appointment of Dr. Grégoire Chevalier as Chief...
Sami Nallamshetty, MD, FACAAI Uses Immunotherapy as a Powerful Tool to Treat Asthma and Allergies
19. Mai 2023 12:37 ET
|
Florida Medical Clinic
TAMPA. Fla., May 19, 2023 (GLOBE NEWSWIRE) -- “People might know that immunotherapy can fight allergies, but it can help asthma sufferers too,” says Dr. Nallamshetty, who specializes in pediatric...
HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration
27. März 2023 04:00 ET
|
AKAMPION
- Study results indicate beneficial effects on airway hyperresponsiveness, remodeling and inflammation Geneva, Switzerland, March 27, 2023 – HpVac SA, a company developing novel preventive and...
Global Allergy Diagnostics Market is Estimated to Reach a Worth of US$ 5.6 Bn in 2033 and Surpass a Revenue of US$ 11.8 Bn at a CAGR of 7.7% During Forecast Period of 2023-33 | FMI
31. Dezember 2022 03:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, Dec. 31, 2022 (GLOBE NEWSWIRE) -- The allergy diagnostics market is estimated to grow at a 7.7% CAGR during the forecast period. The global market was valued at US$ 5.6...
HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
23. November 2022 04:00 ET
|
AKAMPION
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against...
HpVac Announces New Animal Data of its Lead Compound Demonstrating Protection Against Allergic Asthma
18. Oktober 2022 04:00 ET
|
AKAMPION
- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic...
Cat Allergy in Humans Market Size to Grow by USD 5.46 Billion | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends | Vantage Market Research
25. Juli 2022 05:13 ET
|
Vantage Market Research
WASHINGTON, July 25, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Cat Allergy in Humans Market finds that the growing awareness of allergies, the rising...
Cat Allergy in Humans Market Gains Profitable Avenues with Rising Trend of Adopting Cats as Pets, States TMR Study
07. Juni 2022 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 07, 2022 (GLOBE NEWSWIRE) -- The global cat allergy in humans market is estimated to register growth at a CAGR of 6.3% during the forecast period from 2022...
Long-Term Allergy Treatment Available for Yorkville Patients
08. September 2013 10:00 ET
|
Advanced Physical Medicine of Yorkville
YORKVILLE, Ill., Sept. 8, 2013 (GLOBE NEWSWIRE) -- Yorkville chiropractor Dr. Brian Berkey says more individuals are choosing chiropractic and alternative methods of care to manage their allergy...